William Lemieux

About William Lemieux

William Lemieux, With an exceptional h-index of 6 and a recent h-index of 6 (since 2020), a distinguished researcher at Université de Montréal, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A registry‐based population study of the HLA in Québec, Canada

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion

P501 A rare association of DRB1* 08: 04, DQB1* 03: 19, and DRB3* 01: 62 in a cord-blood unit; A case study

KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors

Generation of functional human T cell development in NOD/SCID/IL2rγnull humanized mice without using fetal tissue: Application as a model of HIV infection and persistence

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors

Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study

401.8: Dissecting the Impact of Molecular T-Cell HLA Mismatches in Kidney Graft Failure: A Retrospective Cohort Study

William Lemieux Information

University

Position

CHU Sainte-Justine

Citations(all)

336

Citations(since 2020)

277

Cited By

141

hIndex(all)

6

hIndex(since 2020)

6

i10Index(all)

5

i10Index(since 2020)

5

Email

University Profile Page

Google Scholar

William Lemieux Skills & Research Interests

Immunology

Top articles of William Lemieux

A registry‐based population study of the HLA in Québec, Canada

HLA

2023/12

William Lemieux
William Lemieux

H-Index: 4

Lucie Richard
Lucie Richard

H-Index: 30

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion

Scientific Reports

2023/9/30

P501 A rare association of DRB1* 08: 04, DQB1* 03: 19, and DRB3* 01: 62 in a cord-blood unit; A case study

Human Immunology

2023/9/1

KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors

Frontiers in Immunology

2023/8/21

William Lemieux
William Lemieux

H-Index: 4

Elie Haddad
Elie Haddad

H-Index: 37

Generation of functional human T cell development in NOD/SCID/IL2rγnull humanized mice without using fetal tissue: Application as a model of HIV infection and persistence

Stem Cell Reports

2023/2/14

William Lemieux
William Lemieux

H-Index: 4

Elie Haddad
Elie Haddad

H-Index: 37

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors

Future Virology

2023/2

Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study

Frontiers in Immunology

2022/11/24

401.8: Dissecting the Impact of Molecular T-Cell HLA Mismatches in Kidney Graft Failure: A Retrospective Cohort Study

Transplantation

2022/9/1

William Lemieux
William Lemieux

H-Index: 4

Abstract 28 Comparative Analysis of the Cord Blood Bank in Quebec

Stem Cells Translational Medicine

2022/9/1

William Lemieux
William Lemieux

H-Index: 4

Lucie Richard
Lucie Richard

H-Index: 30

Abstract 25 ECTmatch: Optimizing Small-Scale Cord Blood Banking Through HLA Analysis

Stem Cells Translational Medicine

2022/9/1

Exploitation du potentiel thérapeutique des cellules Natural Killer pour traiter les cancers

2021/4/8

William Lemieux
William Lemieux

H-Index: 4

Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation

2021/4

Patients’ NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing

Cancer Immunology, Immunotherapy

2020/9

William Lemieux
William Lemieux

H-Index: 4

Elie Haddad
Elie Haddad

H-Index: 37

See List of Professors in William Lemieux University(Université de Montréal)